drugset / Trial / NCT00038636
A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and effectiveness of a high dose of ABT-378/ritonavir
Timeline
- Start
- 2000-09
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lopinavir/ritonavir | Unknown | — | — |
| Background | Ritonavir | Other / unclassified | — | — |